Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bovine colostrum is a **cow-derived colostral milk preparation** used as an oral biologically active nutritional product rather than a single defined molecular entity. It contains immunoglobulins, especially IgG, along with lactoferrin, growth factors, cytokines, antimicrobial peptides, oligosaccharides, and other milk bioactives that are intended to support mucosal barrier function, neutralize microbial products in the gut, and modulate innate and adaptive immunity. In the provided public sources it has been studied clinically as enteral prophylaxis in preterm neonates for prevention of necrotizing enterocolitis and sepsis, and as an oral immunonutrition approach in other settings including severe alcohol-associated hepatitis and metabolic or performance-related studies. The evidence described here does not support a clear, consistent therapeutic benefit in neonatal NEC prevention, and the product is best characterized as a heterogeneous nutraceutical or dietary supplement with immunomodulatory and gut-barrier effects rather than a conventional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bovine colostrum.